Phase II trial of darleukin in combination with fibromun in head and neck cancer patients

Trial Profile

Phase II trial of darleukin in combination with fibromun in head and neck cancer patients

Planning
Phase of Trial: Phase II

Latest Information Update: 21 Jan 2016

At a glance

  • Drugs L19-IL2 fusion protein (Primary) ; L19 TNF fusion protein
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Sponsors Philogen
  • Most Recent Events

    • 21 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top